Conflict of interest: Dr Philippe Rousselot received research funding from Novartis and Bristol-Myers Squibb.
Article first published online: 17 SEP 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Hematology
Volume 88, Issue 1, pages 1–4, January 2013
How to Cite
Rousselot, P., Cony-Makhoul, P., Nicolini, F., Mahon, F. X., Berthou, C., Réa, D., Reiffers, J., Bornand, A., Saint-Jean, O., Guilhot, J., Guilhot, F. and on behalf of the French Intergroup For Chronic Myelogenous Leukemia (Fi-LMC) (2013), Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: Results of the AFR04 study. Am. J. Hematol., 88: 1–4. doi: 10.1002/ajh.23330
This study was presented in part at the 2007 Annual Meeting of the American Society of Hematology (Atlanta, December 2007).
- Issue published online: 18 DEC 2012
- Article first published online: 17 SEP 2012
- Accepted manuscript online: 3 SEP 2012 10:05AM EST
- Manuscript Received: 17 AUG 2012
- Manuscript Accepted: 17 AUG 2012
- CHU de Poitiers
This article has been cited by:
- 4Elderly CML patients’ treatment: Considering not only physician's judgment but also co-morbidity indexes, Leukemia Research, 2014, 38, 10, 1156,
- 5First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies, Drugs, 2014, 74, 6, 627, , , , , , ,
- 6Mot en mer spesifikk kreftbehandling?, Tidsskrift for Den norske legeforening, 2014, 134, 10, 1017,
- 7Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV, Annals of Hematology, 2014, 93, 7, 1167, , , , , , , , , , , , , , , , , , , , , , , , ,
- 8Overcoming therapy failure in elderly patients with chronic myeloid leukemia, International Journal of Hematologic Oncology, 2014, 3, 5, 353, ,
- 9Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors, Expert Review of Hematology, 2013, 6, 5, 563, , , , , ,